Overview

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To study the effects of switching from Kaletra to Boosted Reyataz on glucose, lipids and fat in HIV-infected patients.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate
Lopinavir
Ritonavir